Key facts
- Tonic Nutrition’s last known valuation is $19.1M (Jun 2025).
- It has raised $8.5M; the latest was Later Stage VC ($4.0M) in Jun 2025.
- Notable investors include Rianta Capital Zurich, Diego Bevilacqua, Nigel Wray, Pay Close Attention, Peter Tighe — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Tonic Nutrition
- ·The full record, as it builds
Funding rounds
No funding rounds for Tonic Nutrition are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tonic Nutrition
Operator of a health drink brand intended to sell vitamin drinks to reduce the nutrient deficiency crisis. The company's product consists of naturally high doses of vitamin C, zinc, and vitamin D, and is full of plant extracts and immune-boosting vitamins, enabling individuals to support the immune system and aid recovery from colds and flu.
- Sector
- Consumer Products and Services (B2C)
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 7
- Website
- tonichealth.co/
- Ownership
- Privately Held (backing)
Tonic Nutrition doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tonic Nutrition shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tonic Nutrition in its N-PORT filings yet. We sweep new filings monthly.